News

Kenox article on soft mist inhalers featured in Inhalation magazine!

Back

Princeton, NJ – Kenox Pharmaceuticals Inc (Kenox). We’re proud to share that our latest article, "Analytical Challenges and Regulatory Perspectives in the Development of Soft Mist Inhalers (SMIs)," has been featured in Inhalation magazine!

Co-authored by David Stadermann and Sitaram Velaga of Kenox Pharmaceuticals, along with Herbert Wachtel of Boehringer Ingelheim, the article discusses key parameters essential during early development and routine testing of SMIs, while offering insights into the evolving regulatory landscape.

This feature reflects Kenox’s ongoing commitment to innovation in inhalation and drug delivery technologies.

👉Read the full article on Inhalation Magazine  Clickhere